首页> 外文期刊>Coronary artery disease >Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice.
【24h】

Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice.

机译:肝素抑制LDL受体缺陷小鼠的基质金属蛋白酶2的产生并改善动脉粥样硬化。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: This study aimed to find the effects of heparin on atherosclerosis and the production of matrix metalloproteinase (MMP)-2 in low-density lipoprotein receptor-deficient (LDLr(-/-)) mice. METHODS: Sixteen 7-week-old LDLr(-/-) mice were randomized to receive sterile water or heparin. The levels of total cholesterol, high-density lipoprotein cholesterol, triglyceride and homocysteine were measured. Mean lesions area was calculated as the total atherosclerotic lesions area and expressed as a percentage of total luminal surface area. The lesions area was measured blindly by the same person using computer-assisted image analysis. The expression and localization of the MMP-2 was examined by immunohistochemistry. RESULTS: All mice exhibited atherosclerotic lesions in the aortic sinus and aortic surface. Total cholesterol was decreased, while high-density lipoprotein cholesterol was increased in heparin compared with that in control group (P=0.001 and 0.002). Triglyceride was not significantly different between the two groups (P=0.92). The amount of atherosclerotic lesions in the aortic surface was 40.5% lower in heparin group than that in the control group (P<0.001). The mean area of atherosclerotic lesions in the aortic sinus was also less in the heparin group than that in the control group. Coincidently, the expression of MMP-2 in the atherosclerotic lesions in the heparin group was 49.3% lower than that in the control group (P<0.001). CONCLUSION: Heparin can inhibit the production of MMP-2 in the atherosclerotic lesions and improve the atherosclerotic lesions in LDLr(-/-) mice.
机译:目的:本研究旨在探讨肝素对低密度脂蛋白受体缺陷型(LDLr(-/-))小鼠动脉粥样硬化和基质金属蛋白酶(MMP)-2产生的影响。方法:16只7周龄的LDLr(-/-)小鼠随机接受无菌水或肝素。测量总胆固醇,高密度脂蛋白胆固醇,甘油三酸酯和高半胱氨酸的水平。计算平均病变面积为总动脉粥样硬化病变面积,并表示为总腔内表面积的百分比。使用计算机辅助图像分析,由同一人盲目测量病变区域。通过免疫组织化学检查MMP-2的表达和定位。结果:所有小鼠在主动脉窦和主动脉表面均表现出动脉粥样硬化病变。与对照组相比,肝素中总胆固醇降低,而高密度脂蛋白胆固醇升高(P = 0.001和0.002)。两组之间的甘油三酸酯差异无统计学意义(P = 0.92)。肝素组主动脉表面的动脉粥样硬化病变量比对照组低40.5%(P <0.001)。肝素组中主动脉窦的动脉粥样硬化病变的平均面积也小于对照组。巧合的是,肝素组的动脉粥样硬化病变中MMP-2的表达比对照组低49.3%(P <0.001)。结论:肝素可以抑制LDLr(-/-)小鼠动脉粥样硬化病变中MMP-2的产生,改善动脉粥样硬化病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号